SPOTLIGHT: Feds ink HGS contract
Shares of Human Genome Sciences were buoyed today by the news that the federal government will buy $165 million of its anthrax therapy for its biodefense program. Report
Shares of Human Genome Sciences were buoyed today by the news that the federal government will buy $165 million of its anthrax therapy for its biodefense program. Report
SHARE
WITH: